Vanessa McFadden, MD

Publications

• Quality Initiative to Increase Delivery of Adolescent Hospital-Based Reproductive Health Care.

  (McFadden V, Bauer SC, Porada K, Mehta S, Pickett ML.) Hosp Pediatr. 2022 Jan 01;12(1):53-61 PMID: 34918092 12/18/2021

• Letting Residents Lead: Implementing Resident Admission Triage Call Curriculum and Practice.

  (Bauer SC, McFadden V, Madhani K, Kaeppler C, Porada K, Weisgerber MC.) Hosp Pediatr. 2021 06;11(6):579-586 PMID: 34001562 SCOPUS ID: 2-s2.0-85107783318 05/19/2021

• Intent, Substance, and Care: Characteristics of Adolescent Ingestion Hospitalizations.

  (Titus L, Stephany A, Porada K, McFadden V.) Hosp Pediatr. 2021 02;11(2):160-166 PMID: 33468552 01/21/2021

• Did You Get My Snap? Snapchat as a Health Education Tool for Hospitalized Adolescents.

  (Mehta S, Porada K, McFadden V.) J Adolesc Health. 2021 02;68(2):411-413 PMID: 32674962 SCOPUS ID: 2-s2.0-85087742466 07/18/2020

• Severe methemoglobinemia due to topical dapsone misuse in a teenage girl.

  (Yale S, Stefanko N, McCarthy P, McFadden V, McCarthy J.) Pediatr Dermatol. 2020 Mar;37(2):377-378 PMID: 31876314 SCOPUS ID: 2-s2.0-85077160231 12/27/2019

• Addressing Reproductive Health in Hospitalized Adolescents-A Missed Opportunity.

  (McFadden V, Schmitz A, Porada K, Mehta S, Stephany A, Pickett M.) J Adolesc Health. 2019 06;64(6):721-724 PMID: 30878183 SCOPUS ID: 2-s2.0-85062709346 03/18/2019

• Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.

  (Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL 2nd, Burke MJ.) J Pediatr Hematol Oncol. 2017 07;39(5):e254-e258 PMID: 28452856 PMCID: PMC5591641 SCOPUS ID: 2-s2.0-85021364265 04/30/2017

• Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation.

  (McFadden VC, Shalaby RE, Iram S, Oropeza CE, Landolfi JA, Lyubimov AV, Maienschein-Cline M, Green SJ, Kaestner KH, McLachlan A.) PLoS Pathog. 2017 02;13(2):e1006239 PMID: 28235042 PMCID: PMC5342274 SCOPUS ID: 2-s2.0-85014093706 02/25/2017

• Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids.

  (Reese VC, Oropeza CE, McLachlan A.) J Virol. 2013 Jan;87(2):991-7 PMID: 23135717 PMCID: PMC3554059 11/09/2012

• Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.

  (Reese VC, Moore DD, McLachlan A.) J Virol. 2012 Mar;86(5):2760-8 PMID: 22171277 PMCID: PMC3302260 12/16/2011

• Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development.

  (Reese V, Ondracek C, Rushing C, Li L, Oropeza CE, McLachlan A.) Int J Biochem Cell Biol. 2011 Feb;43(2):230-7 PMID: 19941970 PMCID: PMC3773232 11/28/2009

• Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis.

  (Ondracek CR, Rushing CN, Reese VC, Oropeza CE, McLachlan A.) J Virol. 2009 Dec;83(23):12535-44 PMID: 19793822 PMCID: PMC2786732 10/02/2009